Quick View
| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥6.63B | ¥6.97B | −4.9% |
| Operating Income | ¥0.26B | ¥0.24B | +9.5% |
| Ordinary Income | ¥0.29B | ¥0.29B | +0.9% |
| Net Income | ¥0.17B | ¥0.19B | −10.0% |
| ROE | 1.4% | 1.5% | - |
Executive Summary
Although revenue declined, the Company secured an increase in operating income; however, net income decreased due to the recognition of an extraordinary loss. Revenue was ¥6.63B (△4.9% YoY), operating income was ¥0.26B (+9.5%), ordinary income was ¥0.29B (+0.9%), and net income was ¥0.17B (△10.0%). An improvement in the segment profit margin of the Functional Materials Business supported the increase in operating income, but the recognition of an extraordinary loss of ¥0.09B pressured net income.
Factors Affecting Performance
【Revenue】Revenue decreased 4.9% YoY to ¥6.63B, with both businesses reporting lower revenue: the core Functional Materials Business (88.7% of total revenue) declined 4.1%, while the Quality Retention Agents Business declined 10.9%. A slowdown in volume and/or demand pushed down company-wide revenue.
【Profitability】Operating income increased 9.5% YoY to ¥0.26B, primarily because the segment profit margin of the Functional Materials Business improved from 14.6% to 16.7%. Meanwhile, ordinary income increased only marginally, by 0.9% YoY to ¥0.29B. Profit before tax contracted to ¥0.25B (△12.4% YoY) due to the recognition of an extraordinary loss of ¥0.09B, and net income was ¥0.17B (△10.0% YoY). In conclusion, the Company achieved lower revenue but higher operating income; however, due to the impact of extraordinary items, the trend in final profit shifted to a decline at the net income level.
Segment Analysis
The Functional Materials Business generated revenue of ¥5.88B (△4.1% YoY; 88.7% of total revenue) and segment profit of ¥0.98B (+10.1% YoY), with its profit margin improving to 16.7% from 14.6% in the previous year. The Quality Retention Agents Business recorded revenue of ¥0.75B (△10.9% YoY; 11.3% of total revenue) and segment profit of ¥0.04B (+154.7% YoY), with a profit margin of 5.5%; the gap in profit margins versus the Functional Materials Business was approximately 11 points. While it is commendable that profit margins improved in both businesses despite declining revenue, company-wide expenses increased to ¥0.77B from ¥0.67B in the previous year, partially offsetting the improvement at the business-segment level. In addition, the Company changed the classification of intersegment expenses from the current period, and it should be noted that the year-on-year comparison includes adjustments for accounting management purposes.
Key Financial Metrics
【Profitability】The operating margin was 3.9% and the net profit margin was 2.6%; both remain low in absolute terms compared with periods of revenue growth. ROE was 1.4%, comprising the product of a net profit margin of 2.6%, total asset turnover of 0.425x, and financial leverage of 1.25x. Low asset efficiency and profitability are constraining ROE.【Cash Quality】Operating CF and FCF have not been disclosed, so the cash position is assessed based on working capital trends. Work-in-process inventory of ¥1.22B was the largest component of total inventory of ¥1.31B, indicating that funds are tied up based on inventory turnover.【Investment Efficiency】Tangible fixed assets accounted for ¥6.60B of total fixed assets of ¥6.90B, indicating a capital-intensive asset structure. However, relative to an EBIT margin of 3.9%, the Company’s ability to generate returns from invested capital remains limited.【Financial Soundness】The equity ratio was 80.3% (80.8% in the previous year). Current assets of ¥8.70B compared with current liabilities of ¥2.06B indicate that short-term payment capacity remains high.
Cash Flow Analysis
As cash flow statement data have not been disclosed, cash trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥0.36B, down from ¥0.44B in the previous year, and represented a low level of approximately 2.3% of total assets. Accounts receivable and notes receivable of ¥1.05B, electronically recorded monetary claims of ¥1.76B, and inventory of ¥1.31B comprise working capital and tie up funds, indicating significant room for collection improvement and inventory reduction relative to the scale of the business. Accounts payable and notes payable were ¥1.19B, up from ¥1.11B in the previous year, suggesting that an extension of payment terms and/or an increase in purchases may have partially eased cash management. Overall, although profits have been secured, the conversion of funds into cash remains sluggish, and the Company’s actual cash-generation capacity from operating activities will need to be confirmed through future disclosures.
Earnings Quality
Net income was limited to ¥0.17B against ordinary income of ¥0.29B, with the difference mainly attributable to extraordinary items and tax expenses. An extraordinary loss of ¥0.09B was recognized against an extraordinary gain of ¥0.04B, resulting in a net temporary loss factor of ¥0.05B that reduced profit before tax. Income taxes were ¥0.08B, implying an effective tax rate of approximately 31%, and the tax burden also pressured profit to a certain extent. Non-operating income was ¥0.05B, including a foreign exchange gain of ¥0.01B, but remained small in scale. Consequently, the increase in ordinary income (+0.9%) was limited compared with the increase in operating income (+9.5%). Comprehensive income was ¥0.16B, almost at the same level as net income of ¥0.17B, with a foreign currency translation adjustment of △¥0.01B accounting for the primary difference. Overall, the improvement in profitability at the operating level was driven by the core business, while the extraordinary loss, a temporary factor, weakened the quality of final earnings.
Earnings Forecasts and Guidance
The cumulative progress rates through Q3 against the full-year forecasts were 71.3% for revenue, 71.9% for operating income, 77.4% for ordinary income, and 74.0% for net income. Compared with the standard progress rate of 75%, revenue and operating income were slightly below this level, while ordinary income and net income were approximately in line with standard progress. The full-year forecasts are revenue of ¥9.30B (+1.8% YoY), operating income of ¥0.36B (+8.4%), and ordinary income of ¥0.38B (+1.1%). To achieve the plan, the Company will need approximately ¥2.67B in revenue and ¥0.10B in operating income in Q4. Given the declining revenue trend through Q3, demand trends in Q4 will be key to achieving the plan.
Shareholder Returns
The Q2 dividend was ¥50 per share, and the full-year forecast dividend is ¥100 per share, implying an expected year-end dividend of ¥50. The payout ratio against forecast EPS of ¥79.28 is approximately 126%; however, the payout ratio calculated based on cumulative net income for the current period of ¥0.17B (EPS of ¥58.57) is 87.4%, both of which are high relative to the level of earnings. No share buybacks have been confirmed, and shareholder returns consist solely of dividends. The conservative financial structure, reflected in an equity ratio of 80.3%, supports the source of dividend payments; however, as net income is trending downward, the cash flow support for dividends should be monitored continuously.
Risk Factors
-
Decline in inventory and working capital efficiency: Work-in-process inventory accounts for ¥1.22B of total inventory of ¥1.31B, suggesting an extension in inventory days. During demand fluctuations, there is a risk of inventory valuation losses and production adjustments.
-
Low profitability and capital efficiency: An operating margin of 3.9% and ROE of 1.4% are low relative to the Company’s asset base, indicating that the Company holds assets without generating sufficient profit.
-
Risk of recurrence of extraordinary items: In the current period, an extraordinary loss of ¥0.09B reduced profit before tax. If similar temporary losses recur, the volatility of net income may increase.
Industry Benchmark (For Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 3.9% | 8.6% (4.3%–12.7%) | −4.7pt |
| Net Profit Margin | 2.6% | 6.4% (2.8%–10.3%) | −3.9pt |
The Company’s profitability is significantly below the industry median and is positioned in the lower-tier group.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | −4.9% | 3.3% (-2.1%–8.9%) | −8.2pt |
The revenue growth rate is significantly below the industry median and is also below the lower bound of the IQR.
※Source: Compiled by the Company
Key Takeaways from the Earnings Results
-
The segment profit margin of the Functional Materials Business improved to 16.7% (14.6% in the previous year), and the fact that the Company secured an increase in operating income despite declining revenue provides an indication of improvements in the business structure. However, the increase in company-wide expenses partially offset this effect.
-
An operating margin of 3.9% and ROE of 1.4% are both low relative to the industry median and the Company’s asset base, making improvement in capital efficiency an ongoing structural issue.
-
Inventory levels, particularly work-in-process inventory, are high, confirming that funds are tied up in working capital. In addition to earnings growth, improvement in cash-generation capacity through the reduction of inventory and receivables will be a key area for future monitoring.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not constitute a recommendation to invest in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q3 earnings were mixed: lower sales were more than offset at the operating-profit level by gross-margin improvement, while net income declined because of net extraordinary losses. Revenue fell 4.9% YoY to ¥6.629bn. Operating income increased 9.5% to ¥258m despite the sales contraction. Gross profit rose 2.7% to ¥1.740bn, lifting the gross margin by 190bp to 26.2%. The operating margin expanded by 52bp to 3.9%, although it remains below the 5% operating-efficiency threshold. Ordinary income edged up 0.9% to ¥294m, supported by ¥48m of non-operating income, including ¥14m of interest income and ¥7m of foreign-exchange gains. Net income fell 10.0% to ¥170m, and EPS declined to ¥58.57 from ¥65.23. Profit before tax decreased 12.4% to ¥247m because extraordinary income of ¥40m was more than offset by extraordinary losses of ¥87m. The extraordinary losses included ¥47m of fixed-asset disposal losses and ¥40m of losses from reduction of non-current assets, while extraordinary income consisted principally of ¥40m of insurance proceeds. The effective tax rate was 31.1%, producing a tax burden of 0.688, slightly below the 0.70 normal reference level but not indicative of an exceptional tax distortion. The Functional Materials business remained the core business, generating 88.7% of segment revenue and 96.0% of aggregate segment profit. Functional Materials and Quality Preservation Agents both improved segment profitability despite declining sales. At the consolidated level, however, unallocated corporate costs rose 13.7% to ¥767m, moderating the conversion of segment profit gains into operating income. The balance sheet remains conservatively financed, with an 80.3% capital adequacy ratio, 421.9% current ratio, and 0.25x debt-to-equity ratio. Working-capital efficiency is the principal operational concern, as reported inventory-day measures of 194 days and 73 days are both above their respective warning thresholds and the reported cash conversion cycle is 171 days. Full-year guidance implies a recovery in Q4 sales and earnings, but the FY dividend forecast of ¥100 per share exceeds forecast EPS of ¥79.28, making dividend funding and inventory normalization key issues for the remainder of the year.
Profitability Analysis
Annualized DuPont ROE is 1.8%, calculated as a 2.6% net profit margin multiplied by 0.567x asset turnover and 1.25x financial leverage. The subdued ROE is principally a profitability and asset-efficiency issue rather than a leverage issue, as the company operates with a low financial-leverage multiple and substantial equity capital. Annualized asset turnover of 0.567x is modest for a manufacturing business with PPE equal to 42.3% of total assets. The largest positive operating change was gross-margin expansion: gross margin rose to 26.2% from 24.3%, a 190bp improvement, despite a 4.9% decline in revenue. SG&A increased 1.5% to ¥1.481bn while revenue declined, causing the SG&A-to-sales ratio to rise by approximately 142bp to 22.3%. Nevertheless, the gross-margin gain exceeded this negative operating-leverage effect, raising the operating margin by 52bp to 3.9%. The LOW_OPERATING_EFFICIENCY alert is therefore valid: a 3.9% EBIT margin is below the 5% reference level, leaving limited protection against further volume declines, input-cost pressure, or yen movements. The CAPITAL_EFFICIENCY alert is also material: reported ROIC of 1.9% is below 5%, indicating that the current earnings generated from the operating asset base remain weak. The five-factor DuPont result shows a 0.958 interest burden and 23.28x interest coverage, confirming that financing costs are not the cause of the low return profile. Functional Materials segment profit increased 10.1% to ¥984m on a 4.1% sales decline to ¥5.881bn, lifting its segment margin by about 210bp to 16.7%. Quality Preservation Agents segment profit increased 154.7% to ¥41m despite a 10.9% revenue decline to ¥748m, with the segment margin improving by about 360bp to 5.5%; this reflects a low prior-year earnings base and remains materially below the Functional Materials margin. Segment-profit comparability requires care because the company changed expense-allocation methods; current Functional Materials segment profit benefited by ¥82m relative to the former presentation, with an equivalent increase in corporate-cost adjustments. The core Functional Materials business demonstrates favorable product or cost mix, but sustained consolidated-margin improvement requires containment of corporate costs and a return to revenue growth.
Growth Assessment
The revenue decline was broad-based across the two reported businesses. Functional Materials revenue declined 4.1% YoY to ¥5.881bn, while Quality Preservation Agents revenue fell 10.9% to ¥748m. The gross-profit increase despite lower revenue suggests improved pricing, product mix, production efficiency, or input-cost conditions, but the decline in both segment sales means the sustainability of the margin gain must be demonstrated through renewed volume growth. Functional Materials remains the main earnings driver and its higher segment margin provides the most significant upside if demand recovers. Quality Preservation Agents delivered a strong percentage increase in segment profit, but its ¥41m segment profit remains small relative to Functional Materials and does not materially diversify group earnings. Full-year company guidance calls for revenue of ¥9.300bn, up 1.8% YoY, operating income of ¥360m, up 8.4%, ordinary income of ¥380m, up 1.1%, and net income of ¥230m. Q3 cumulative progress against full-year guidance is 71.3% for sales, 71.7% for operating income, 77.4% for ordinary income, and 74.0% for net income. Sales and operating-income progress are each 3.7 percentage points below the standard 75% Q3 pace, while ordinary income is 2.4 points ahead of that pace. The implied Q4 requirement is ¥2.671bn of revenue and ¥102m of operating income, equivalent to a 3.8% operating margin. This is slightly below the Q3 cumulative operating margin of 3.9%, so the operating-profit target is arithmetically achievable if sales stabilize and gross-margin gains persist. The principal growth constraint is not debt capacity but the need to translate segment-level profitability into consolidated earnings while absorbing elevated corporate and development-related spending.
Financial Health
Financial health is strong. Total equity was ¥12.521bn against total liabilities of ¥3.081bn, resulting in an 80.3% capital adequacy ratio and a conservative 0.25x debt-to-equity ratio. The 421.9% current ratio and 358.3% quick ratio indicate ample current-asset coverage of current liabilities, and working capital was ¥6.640bn. There is no current-ratio or debt-to-equity warning: the current ratio is well above 1.0 and debt-to-equity is far below 2.0. Current liabilities of ¥2.062bn are covered by current assets of ¥8.702bn, limiting near-term maturity-mismatch risk. Cash and deposits were ¥359m, while lease obligations totaled ¥690m, comprising ¥33m current and ¥657m non-current; the lease position is manageable in the context of the large current-asset base and low leverage. Trade payables were ¥1.191bn, while electronically recorded monetary claims were ¥1.758bn and trade receivables were ¥1.054bn, reinforcing the importance of collections and working-capital management. PPE totaled ¥6.600bn, or 42.3% of assets, reflecting a capital-intensive manufacturing asset base. Net defined-benefit liabilities were ¥361m and should be monitored as a long-term obligation, although they are modest relative to equity. Intangible assets rose from ¥28m to ¥66m, up 133.7% YoY. The increase is principally associated with ¥42m of software in progress, and its magnitude remains immaterial at 0.4% of total assets. The low intangible-asset ratio and absence of reported goodwill indicate that the balance sheet is not dependent on acquisition-related intangible values. Accumulated depreciation on machinery of ¥11.442bn substantially exceeds the ¥1.023bn gross machinery balance, indicating that the productive asset base includes heavily depreciated equipment and that maintenance or modernization discipline remains important.
Notable B/S Changes
Intangible assets: +¥0.38bn (+133.7%) to ¥0.66bn, principally associated with ¥0.42bn of software in progress; the increase should be monitored for project completion and capitalization discipline, although intangibles remain only 0.4% of total assets. Raw materials: +¥0.20bn (+27.9%) to ¥0.93bn while revenue declined 4.9%; this increases working-capital intensity and contributes to the elevated inventory-day risk. Work in process: +¥0.18bn (+16.9%) to ¥1.22bn; the increase alongside lower sales may indicate a longer production cycle or slower demand absorption. Electronically recorded monetary claims: +¥0.05bn (+3.1%) to ¥1.76bn; collection efficiency remains important given the reported 171-day cash conversion cycle. Construction in progress: +¥0.07bn (+292.4%) to ¥0.09bn; the absolute amount is small, but it indicates an expanding investment pipeline.
Cash Flow Quality
Reported cash conversion-cycle indicators point to operational cash-conversion pressure. The LONG_CCC alert is material: the reported annualized cash conversion cycle of 171 days is well above the 120-day warning level, tying up capital in the operating cycle and raising sensitivity to demand changes. The HIGH_INVENTORY_DAYS alert based on 194 days is particularly significant for a manufacturing company, as it is far above the 90-day warning threshold and suggests elevated inventory carrying, obsolescence, and markdown risk if production or demand is misaligned. A second HIGH_INVENTORY_DAYS alert reports 73 days against a 60-day benchmark; although less severe than the 194-day measure, it still signals inventory efficiency below the applicable manufacturing benchmark. Together, the two reported inventory-day measures indicate that inventory management requires attention under both measurement bases. Reported inventory was ¥1.313bn and was broadly unchanged YoY, but raw materials rose 27.9% to ¥931m and work in process increased 16.9% to ¥1.224bn. The build-up in raw materials and work in process alongside a sales decline may reflect procurement timing, production-cycle length, or weaker demand absorption; in each case, it increases the risk that cash remains tied up in operations. Electronically recorded monetary claims rose 3.1% to ¥1.758bn while trade receivables declined 4.5% to ¥1.054bn, indicating that receivable exposure remains substantial despite lower reported sales. Trade payables increased 7.3% to ¥1.191bn, providing some supplier financing, but not enough to eliminate the reported long cash-conversion-cycle concern. Net income was affected by a net ¥47m extraordinary loss, so statutory profit understates operating earnings before these items. The mix of insurance income and asset-related losses should not be treated as recurring operating cash generation. Interest coverage of 23.28x supports debt-service capacity, but improving inventory turnover and cash conversion is more important than financing risk for earnings quality.
Dividend Sustainability
The company has paid an interim Q2 dividend of ¥50 per share and forecasts a full-year dividend of ¥100 per share. Based on forecast EPS of ¥79.28, the forecast dividend payout ratio is approximately 126.1%, above both the 60% sustainability reference level and the 100% warning threshold. Based on Q3 cumulative net income of ¥170m, the calculated payout ratio for the ¥50 interim dividend alone is 87.4%. The planned full-year dividend therefore relies on earnings generated in Q4, accumulated retained earnings, or both rather than being covered by forecast-period earnings alone. Retained earnings of ¥9.564bn provide a substantial balance-sheet buffer, and the 80.3% equity ratio supports the company’s capacity to maintain shareholder distributions in the near term. However, a dividend above forecast earnings reduces retained capital available for plant renewal, development spending, and working-capital requirements. The elevated inventory days and 171-day cash conversion cycle make liquidity conversion more important when assessing the practical sustainability of the payout. The stated ¥100 per share dividend should be evaluated against delivery of the ¥230m full-year net-income target and progress in releasing working capital.
Risk Assessment
Business risks include Demand risk: revenue declined in both Functional Materials (-4.1% YoY) and Quality Preservation Agents (-10.9%), demonstrating that group sales weakness is broad-based rather than isolated., Margin risk: the consolidated 3.9% EBIT margin provides limited protection against lower utilization, raw-material and energy-cost inflation, pricing pressure, or unfavorable product mix., Inventory risk: reported inventory-day alerts of 194 days and 73 days, together with a 171-day cash conversion cycle, raise the likelihood of excess-stock, obsolescence, and production-planning risk., Manufacturing asset risk: PPE represents 42.3% of total assets and the machinery base is heavily depreciated, making maintenance, replacement timing, and production reliability important., Foreign-exchange risk: the company recorded ¥7m of foreign-exchange gains in Q3, indicating some exposure to currency movements; a reversal would affect ordinary income., Industry-specific materials-manufacturing risk: profitability is exposed to volatile input costs, energy costs, customer inventory adjustments, and quality-control requirements in functional-material production..
Financial risks include Low capital efficiency: the 1.9% ROIC alert and annualized 1.8% ROE indicate low returns relative to the operating asset and equity base., Dividend coverage risk: the FY dividend forecast of ¥100 per share represents an approximately 126.1% payout ratio against forecast EPS of ¥79.28., Working-capital funding risk: lengthy inventory holding and a 171-day cash conversion cycle can absorb liquidity even though reported balance-sheet liquidity is strong., Lease obligation monitoring: lease obligations total ¥690m, exceeding cash and deposits of ¥359m, although the overall leverage profile remains conservative..
Key concerns include The LOW_OPERATING_EFFICIENCY alert is justified because the 3.9% EBIT margin is below 5%; it limits earnings resilience and makes revenue recovery necessary for meaningful return improvement., The CAPITAL_EFFICIENCY alert is justified because ROIC is 1.9%, below 5%; the low return profile weakens the economic value creation case despite strong solvency., The HIGH_INVENTORY_DAYS alert at 194 days is a high-impact concern because it materially exceeds the 90-day warning threshold and can lead to inventory valuation and cash-lockup risk., The HIGH_INVENTORY_DAYS alert at 73 days is also relevant against its 60-day benchmark; it confirms that inventory efficiency remains weak even under a less conservative measurement basis., The LONG_CCC alert at 171 days is high impact because it is well above the 120-day warning level; management’s ability to reduce stock and accelerate the operating cycle is central to earnings-quality improvement., Corporate costs increased 13.7% to ¥767m while revenue fell, and continued growth in unallocated expenses could prevent segment-margin gains from translating into stronger consolidated profitability., Net income was reduced by a net ¥47m extraordinary loss, so the Q3 profit decline was more severe below ordinary income than at the operating-income level..
Investment Implications
Key takeaways include Operating income grew 9.5% despite a 4.9% revenue decline, driven by a 190bp improvement in gross margin., Functional Materials is the core business, with ¥5.881bn of revenue and ¥984m of segment profit, and remains the primary determinant of group earnings., The balance sheet is a clear strength, with an 80.3% equity ratio, 421.9% current ratio, 358.3% quick ratio, and 0.25x debt-to-equity ratio., Low returns remain the central valuation-relevant operating issue: annualized ROE is 1.8%, reported ROIC is 1.9%, and EBIT margin is 3.9%., Inventory efficiency and the 171-day cash conversion cycle are the most important operational risks to monitor., The FY guidance requires only a 3.8% Q4 operating margin, but the projected ¥100 per share dividend exceeds forecast earnings per share..
Metrics to watch include Functional Materials revenue trend and segment margin, Quality Preservation Agents revenue recovery and margin durability, Consolidated gross margin versus corporate-cost growth, Operating margin relative to the 5% efficiency threshold, Reported inventory days under both disclosed measurement bases, Cash conversion cycle and changes in raw-material and work-in-process balances, Full-year progress toward ¥9.300bn revenue, ¥360m operating income, and ¥230m net income, Dividend payout ratio relative to forecast EPS and retained-earnings usage, PPE renewal and machinery maintenance requirements.
Regarding relative positioning, The company is financially conservative relative to standard solvency benchmarks, with strong liquidity, low leverage, and no material acquisition-intangible burden. Relative to manufacturing profitability and capital-efficiency benchmarks, however, its 3.9% EBIT margin, 1.9% ROIC, annualized 1.8% ROE, and extended operating cash cycle place it in a weaker operating-efficiency position. The investment case is therefore more dependent on converting the current gross-margin improvement into sustained revenue growth and better working-capital productivity than on balance-sheet repair.